Back to results
US 8,278,413 B2Granted
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
AssigneeXigen SA
InventorChristophe Bonny
Life of this patent
Estimating the term…
Abstract
The invention provides cell-permeable peptides that bind to JNK proteins and inhibit JNK-mediated effects in JNK-expressed cells.
Claims7
A chimeric peptide capable of inhibiting the activation of at least one c-jun amino terminal kinase (JNK) signaling pathway, said chimeric peptide being 35 amino acids or less in length, comprising a first domain and a second domain linked by a covalent bond at either the N-terminal or the C-terminal end of the first domain, wherein the first domain comprises the amino acid sequence of SEQ ID NO:
- 8, and the second domain comprises a JNK inhibitor sequence selected from the group consisting of
- a) a peptide with the amino acid sequence of SEQ ID NO:3 and
- b) a peptide having at least 80% sequence identity to SEQ ID NO:3,
- wherein the JNK inhibitor sequence is capable of inhibiting the activation of at least one JNK signaling pathway.
1 more element
A peptide consisting of the amino acid sequence of SEQ ID NO:3.
Dependencies are inferred from the claim text.